Omnicell (OMCL) reported earnings 30 days ago. What's next for the stock?
OMCL shares soar 57.3% in a year as SaaS growth, Autonomous Pharmacy momentum and OmniSphere adoption boost outlook.
Omnicell, Inc. (OMCL) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, OMCL's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
The average of price targets set by Wall Street analysts indicates a potential upside of 39.9% in Omnicell (OMCL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Omnicell, Inc. (OMCL) Shareholder/Analyst Call Prepared Remarks Transcript
Omnicell, Inc. (OMCL) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Does Omnicell (OMCL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
The mean of analysts' price targets for Omnicell (OMCL) points to a 41.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
OMCL posts Q1 earnings and revenue beat with surging margins and strong demand, sending shares sharply higher after results.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.